IRCT201506271159N17已完成1 期
Transplantation of autologous skin fibroblast cells for treatment of nasolabial wrinkles
Skin and Stem Cell Research Center, Maryam aley, South kamraneye, Tehran, Iran0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 35 years 至 55 years（—）
- 性别
- All
入选标准
- •age about 35 to 55 years old;- Patients with mild to moderate wrinkles according to Glogue scale I-III; No coagulation disorders and use of anti coagulated drugs; No infection in treated site; No fever able diseases; No chronic liver diseases; No pregnancy or breast-feeding; Having no anatomic disorder in face; Normal mental health; Having a good cooperation with research team.
排除标准
- •being smokers or drinkers; any past skin intervention in face; Having many wrinkles on the face; type of 1 or 5 of wrinkle scoring; having a mental disorder; having an obsessed disorder; having any skin disorder; having any major disorder; having a systemic disorder; having an oral disorder;
研究者
相似试验
进行中（未招募）
1 期
Transplantation of Autologous Stem Cells for the treatment of corneal diseasesEUCTR2018-000523-14-ESniversidad Miguel Hernandez30
已完成
不适用
Suspension from Patients own skin for correction of depressed area of faceCTRI/2016/11/007500AIIMS New Delhi10
尚未招募
1 期
Transplantation of stem cells for the treatment of type 1 diabetes.Type 1 diabetes mellitus (T1DM).Type 1 diabetes mellitusIRCT20210925052566N1Endocrinology and Metabolism Research Institute30
已完成
不适用
Autologous peripheral blood stem cell transplantation using Thiotepa, Carboplatin and Etoposide conditioning in patients with relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)JPRN-UMIN000026084agoya University Graduate School of Medicine10
已完成
不适用
Autologous peripheral blood stem cell transplantation as consolidation for high risk diffuse large B-cell lymphoma:A phase II studyDiffuse Large B-Cell Lymphoma:IPI high risk group, CR1JPRN-UMIN000012546ishiwaki Municipal Hospital18